Interesting 'poster' heading (p2), seems to allude some positive P2-CALM updates, good news...
'Phase II CALM Extension study: Intratumoural Coxsackievirus A21 increases immune-cell infiltrates and up-regulates immunecheckpoint molecules in the tumour micro-environment'
Bring on mid-October...
ML
- Forums
- ASX - By Stock
- VLA
- Ann: VLA to Present CAVATAK Clinical Data at Upcoming Conferences-VLA.AX
Ann: VLA to Present CAVATAK Clinical Data at Upcoming Conferences-VLA.AX, page-2
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online